A tumor suppressor DLC1: The functions and signal pathways
Y Zhang, G Li - Journal of Cellular Physiology, 2020 - Wiley Online Library
Deleted in liver cancer‐1 (DLC1), a potential tumor suppressor, acts as a GTPase‐activating
protein for Rho family members. In many human cancers, the DLC1 expression is frequently …
protein for Rho family members. In many human cancers, the DLC1 expression is frequently …
DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA
Deleted-in-liver cancer 1 (DLC1) exerts its tumor suppressive function mainly through the
Rho-GTPase–activating protein (RhoGAP) domain. When activated, the domain promotes …
Rho-GTPase–activating protein (RhoGAP) domain. When activated, the domain promotes …
Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma
X Yang, F Hu, JA Liu, S Yu, MPL Cheung, X Liu, IOL Ng… - Oncogene, 2020 - nature.com
A Rho GTPase-activating protein (RhoGAP), deleted in liver cancer 1 (DLC1), is known to
function as a tumor suppressor in various cancer types; however, whether DLC1 is a tumor …
function as a tumor suppressor in various cancer types; however, whether DLC1 is a tumor …